|View printer-friendly version|
|Dextera Surgical Receives Expanded Indication in Solid Organ Surgery for MicroCutter 5/80™|
-- Including Liver, Pancreas, Kidney and Spleen Surgical Procedures –
“The small size and large degree of articulation provided by the
MicroCutter 5/80 is especially beneficial in maneuvering within the
confined spaces around solid internal organs,” said
The MicroCutter 5/80 Stapler and MicroCutter 30 White, Blue and Curved Tip White and Blue Reloads are intended for transection and resection in multiple open or minimally invasive urologic, thoracic, and pediatric surgical procedures, as well as application for transection, resection, and/or creation of anastomoses in the small and large intestine, and the transection of the appendix. With the current clearance, the MicroCutter 5/80 Stapler and MicroCutter 30 White and Curved Tip White Reloads may additionally be used in conjunction with open solid organ parenchymal dissection techniques on veins four to five millimeters in diameter and arteries three to seven millimeters in diameter.
“This clearance expands our reach in
About Dextera Surgical
Dextera Surgical designs and manufactures proprietary stapling devices for minimally invasive surgical procedures. In the U.S., surgical staplers are routinely used in more than one million minimally invasive laparoscopic, video-assisted or robotic-assisted surgical procedures annually.
Dextera Surgical also markets the only automated anastomosis devices for coronary artery bypass graft (CABG) surgery on the market today: the C-Port® Distal Anastomosis Systems and PAS-Port® Proximal Anastomosis System. These products, sold by Dextera Surgical under the Cardica brand name, have demonstrated long-term reliable clinical performance for more than a decade.
The statements in this press release regarding the beneficial use of the
MicroCutter 5/80 in open solid organ surgery, the expanded indication
representing an additional 44,000 procedures in
Dextera Surgical Inc.